About: Highlights of the 30th International Conference on Antiviral Research

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Highlights of the 30th International Conference on Antiviral Research Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Highlights of the 30th International Conference on Antiviral Research
Creator	Andrei, Graciela Bray, Mike Janeba, Zlatko Carter, Kara Sampath, Aruna Anthony, R Chase, Chevy Est, A Hodge, Vere Schang, Luis Sofia, Michael Tarbet, E
Source	Elsevier; Medline; PMC
abstract	Abstract The 30th International Conference on Antiviral Research (ICAR) was held in Atlanta, GA, USA from May 18 to 21, 2017. This report provides an account of award lectures, invited keynote addresses and oral presentations during the meeting. The 2017 Gertrude Elion Memorial Lecture Award by Michael Sofia highlighted one of the most important accomplishments in recent drug discovery in antiviral research, the identification of the hepatitis C virus direct-acting antiviral sofosbuvir and new alternatives to combat hepatitis B virus (HBV) infection. The Antonín Holý Lecture Award by David Chu on medicinal chemistry provided an overview of early developments of nucleoside analogs for the treatment of HIV and varicella zoster virus infection and how this knowledge serves to develop new drugs targeting HBV. Priscilla Yang gave the first ISAR Women in Science lecture. She reported on pharmacological validation of new antiviral targets for dengue, Zika and other flaviviruses. The William Prusoff Young Investigator Lecture Award by Maaike Everts described the Alabama Drug Discovery Alliance and the Antiviral Drug Discovery and Development Consortium, and how they are helping to accelerate the development of new antivirals. The 30th ICAR was a success in promoting new discoveries in antiviral drug development and research. The 31st ICAR will be held in Porto, Portugal, June 11–15, 2018.
has issue date	2017-09-30(xsd:dateTime)
bibo:doi	10.1016/j.antiviral.2017.07.017
bibo:pmid	28774800
has license	els-covid
sha1sum (hex)	5cbdd22a78cb4afbec6b28e3285232b5f1cb7f9d
schema:url	https://doi.org/10.1016/j.antiviral.2017.07.017
resource representing a document's title	Highlights of the 30th International Conference on Antiviral Research
has PubMed Central identifier	PMC7127040
has PubMed identifier	28774800
schema:publication	Antiviral Research
resource representing a document's body	covid:5cbdd22a78cb4afbec6b28e3285232b5f1cb7f9d#body_text
is schema:about of	named entity 'Drug Discovery' named entity 'combat' named entity 'ICAR' named entity 'alternatives' named entity 'hepatitis C virus' named entity 'Alabama' named entity 'DEVELOPMENTS' named entity 'EARLY' named entity 'INFECTION' named entity 'LECTURE' named entity 'REPORTED' named entity 'HOW' named entity 'INVESTIGATOR' named entity 'PORTO' named entity 'HEPATITIS B VIRUS' named entity 'ANTIVIRALS' named entity 'HBV' named entity 'ALLIANCE' named entity 'VALIDATION' named entity 'SOFOSBUVIR' named entity 'PHARMACOLOGICAL' named entity 'TARGETS' named entity 'CONSORTIUM' named entity 'HELD' named entity 'JUNE' named entity 'TREATMENT' named entity 'CHU' named entity 'KNOWLEDGE' named entity 'AWARD' named entity 'ANTIVIRAL' named entity 'DESCRIBED' named entity 'DRUG DISCOVERY' named entity 'GAVE' named entity 'ACCOMPLISHMENTS' named entity 'WOMEN' named entity 'ADN' named entity 'DRUG DISCOVERY AND DEVELOPMENT' named entity 'RECENT' named entity 'PROVIDED' named entity 'IMPORTANT' named entity 'HIV' named entity 'OVERVIEW' named entity '2018' named entity 'RESEARCH' named entity 'MEDICINAL CHEMISTRY' named entity 'DENGUE' named entity 'DEVELOPMENT' named entity 'ACCELERATE' named entity 'YANG' named entity 'SUCCESS' named entity 'NEW' named entity 'SCIENCE' named entity 'ISAR' named entity 'IDENTIFICATION' named entity 'YOUNG' named entity 'VARICELLA ZOSTER VIRUS INFECTION' named entity 'ONE OF' named entity 'ICAR' named entity 'DRUGS TARGETING' named entity 'WAS A' named entity 'COMBAT' named entity 'ANTON' named entity 'FLAVIVIRUSES' named entity 'PROMOTING' named entity 'ZIKA' named entity 'PORTUGAL' named entity 'NUCLEOSIDE ANALOGS' named entity 'DRUG DEVELOPMENT' named entity 'ALABAMA' named entity 'DAVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software